252 related articles for article (PubMed ID: 16239728)
1. Structural analysis of human liver glyceraldehyde-3-phosphate dehydrogenase.
Ismail SA; Park HW
Acta Crystallogr D Biol Crystallogr; 2005 Nov; 61(Pt 11):1508-13. PubMed ID: 16239728
[TBL] [Abstract][Full Text] [Related]
2. Conformational changes in Leishmania mexicana glyceraldehyde-3-phosphate dehydrogenase induced by designed inhibitors.
Suresh S; Bressi JC; Kennedy KJ; Verlinde CL; Gelb MH; Hol WG
J Mol Biol; 2001 Jun; 309(2):423-35. PubMed ID: 11371162
[TBL] [Abstract][Full Text] [Related]
3. Selective tight binding inhibitors of trypanosomal glyceraldehyde-3-phosphate dehydrogenase via structure-based drug design.
Aronov AM; Verlinde CL; Hol WG; Gelb MH
J Med Chem; 1998 Nov; 41(24):4790-9. PubMed ID: 9822549
[TBL] [Abstract][Full Text] [Related]
4. Structural basis for selective inhibition of trypanosomatid glyceraldehyde-3-phosphate dehydrogenase: molecular docking and 3D QSAR studies.
Guido RV; Oliva G; Montanari CA; Andricopulo AD
J Chem Inf Model; 2008 Apr; 48(4):918-29. PubMed ID: 18303835
[TBL] [Abstract][Full Text] [Related]
5. Discovery of novel Trypanosoma cruzi glyceraldehyde-3-phosphate dehydrogenase inhibitors.
Freitas RF; Prokopczyk IM; Zottis A; Oliva G; Andricopulo AD; Trevisan MT; Vilegas W; Silva MG; Montanari CA
Bioorg Med Chem; 2009 Mar; 17(6):2476-82. PubMed ID: 19254846
[TBL] [Abstract][Full Text] [Related]
6. Crystal structure of Leishmania mexicana glycosomal glyceraldehyde-3-phosphate dehydrogenase in a new crystal form confirms the putative physiological active site structure.
Kim H; Hol WG
J Mol Biol; 1998 Apr; 278(1):5-11. PubMed ID: 9571030
[TBL] [Abstract][Full Text] [Related]
7. The glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase works as an arsenate reductase in human red blood cells and rat liver cytosol.
Gregus Z; Németi B
Toxicol Sci; 2005 Jun; 85(2):859-69. PubMed ID: 15788719
[TBL] [Abstract][Full Text] [Related]
8. Engineered glycolytic glyceraldehyde-3-phosphate dehydrogenase binds the anti conformation of NAD+ nicotinamide but does not experience A-specific hydride transfer.
Eyschen J; Vitoux B; Marraud M; Cung MT; Branlant G
Arch Biochem Biophys; 1999 Apr; 364(2):219-27. PubMed ID: 10190977
[TBL] [Abstract][Full Text] [Related]
9. Evidence for the two phosphate binding sites of an analogue of the thioacyl intermediate for the Trypanosoma cruzi glyceraldehyde-3-phosphate dehydrogenase-catalyzed reaction, from its crystal structure.
Castilho MS; Pavão F; Oliva G; Ladame S; Willson M; Périé J
Biochemistry; 2003 Jun; 42(23):7143-51. PubMed ID: 12795610
[TBL] [Abstract][Full Text] [Related]
10. Structure of apo-glyceraldehyde-3-phosphate dehydrogenase from Palinurus versicolor.
Shen YQ; Li J; Song SY; Lin ZJ
J Struct Biol; 2000 May; 130(1):1-9. PubMed ID: 10806086
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure of the glyceraldehyde-3-phosphate dehydrogenase from the hyperthermophilic archaeon Sulfolobus solfataricus.
Isupov MN; Fleming TM; Dalby AR; Crowhurst GS; Bourne PC; Littlechild JA
J Mol Biol; 1999 Aug; 291(3):651-60. PubMed ID: 10448043
[TBL] [Abstract][Full Text] [Related]
12. Structural analyses to identify selective inhibitors of glyceraldehyde 3-phosphate dehydrogenase-S, a sperm-specific glycolytic enzyme.
Danshina PV; Qu W; Temple BR; Rojas RJ; Miley MJ; Machius M; Betts L; O'Brien DA
Mol Hum Reprod; 2016 Jun; 22(6):410-26. PubMed ID: 26921398
[TBL] [Abstract][Full Text] [Related]
13. Structure of glyceraldehyde-3-phosphate dehydrogenase from Plasmodium falciparum.
Satchell JF; Malby RL; Luo CS; Adisa A; Alpyurek AE; Klonis N; Smith BJ; Tilley L; Colman PM
Acta Crystallogr D Biol Crystallogr; 2005 Sep; 61(Pt 9):1213-21. PubMed ID: 16131754
[TBL] [Abstract][Full Text] [Related]
14. Dual coenzyme specificity of photosynthetic glyceraldehyde-3-phosphate dehydrogenase interpreted by the crystal structure of A4 isoform complexed with NAD.
Falini G; Fermani S; Ripamonti A; Sabatino P; Sparla F; Pupillo P; Trost P
Biochemistry; 2003 Apr; 42(16):4631-9. PubMed ID: 12705826
[TBL] [Abstract][Full Text] [Related]
15. Crystal structure of glycosomal glyceraldehyde-3-phosphate dehydrogenase from Leishmania mexicana: implications for structure-based drug design and a new position for the inorganic phosphate binding site.
Kim H; Feil IK; Verlinde CL; Petra PH; Hol WG
Biochemistry; 1995 Nov; 34(46):14975-86. PubMed ID: 7578111
[TBL] [Abstract][Full Text] [Related]
16. Computational study of glyceraldehyde-3-phosphate dehydrogenase of Entamoeba histolytica: implications for structure-based drug design.
Kundu S; Roy D
J Biomol Struct Dyn; 2007 Aug; 25(1):25-33. PubMed ID: 17676935
[TBL] [Abstract][Full Text] [Related]
17. The development of an immobilized enzyme reactor containing glyceraldehyde-3-phosphate dehydrogenase from Trypanosoma cruzi: the effect of species' specific differences on the immobilization.
Cardoso CL; de Moraes MC; Guido RV; Oliva G; Andricopulo AD; Wainer IW; Cass QB
Analyst; 2008 Jan; 133(1):93-9. PubMed ID: 18087619
[TBL] [Abstract][Full Text] [Related]
18. Trypanosoma cruzi glycosomal glyceraldehyde-3-phosphate dehydrogenase: structure, catalytic mechanism and targeted inhibitor design.
Souza DH; Garratt RC; Araújo AP; Guimarães BG; Jesus WD; Michels PA; Hannaert V; Oliva G
FEBS Lett; 1998 Mar; 424(3):131-5. PubMed ID: 9580189
[TBL] [Abstract][Full Text] [Related]
19. Glyceraldehyde-3-phosphate dehydrogenase inactivation by peroxynitrite.
Souza JM; Radi R
Arch Biochem Biophys; 1998 Dec; 360(2):187-94. PubMed ID: 9851830
[TBL] [Abstract][Full Text] [Related]
20. Crystal structure of glyceraldehyde-3-phosphate dehydrogenase 1 from methicillin-resistant Staphylococcus aureus MRSA252 provides novel insights into substrate binding and catalytic mechanism.
Mukherjee S; Dutta D; Saha B; Das AK
J Mol Biol; 2010 Sep; 401(5):949-68. PubMed ID: 20620151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
